Advanced
  Home Compare Reports

Comparison with Similar Reports

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UT...

Publisher:       

# of Pages:        237

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.2 MARKETS COVERED 33
FIGURE 1 URINALYSIS MARKET SEGMENTATION 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.2 RESEARCH APPROACH 37
FIGURE 2 URINALYSIS MARKET: RESEARCH DESIGN 37
2.2.1 SECONDARY DATA 38
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY DATA 39
2.2.2.1 Key data from primary sources 39
2.2.2.2 Key industry insights 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 41
2.3 MARKET SIZE ESTIMATION 41
2.3.1 BOTTOM-UP APPROACH 41
2.3.1.1 Approach 1: Company revenue estimation approach 42
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 42
2.3.1.2 Approach 2: Market estimation from the parent market 42
FIGURE 5 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET 42
2.3.1.3 Approach 3: Presentations of companies and primary interviews 43
2.3.1.4 Growth rate assumptions 43
2.3.1.5 CAGR projections 43
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.3.2 TOP-DOWN APPROACH 44
FIGURE 7 URINALYSIS MARKET: TOP-DOWN APPROACH 44
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 8 DATA TRIANGULATION METHODOLOGY 45
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET 46
2.7 COVID-19 HEALTH ASSESSMENT 46
2.8 COVID-19 ECONOMIC ASSESSMENT 46
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 46
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 47
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 48
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE URINALYSIS MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 11 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 50
FIGURE 12 URINALYSIS MARKET, BY TEST TYPE, 2021 VS. 2026 (USD MILLION) 51
FIGURE 13 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 51
FIGURE 14 URINALYSIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 52
FIGURE 15 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 52
4 PREMIUM INSIGHTS 54
4.1 URINALYSIS MARKET OVERVIEW 54
FIGURE 16 THE RISING ADOPTION OF POC DIAGNOSTICS IS A KEY FACTOR EXPECTED TO SUPPORT MARKET GROWTH DURING THE FORECAST PERIOD 54
4.2 URINALYSIS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 CONSUMABLES SEGMENT TO COMMAND THE LARGEST SHARE OF THE MARKET, BY PRODUCT, IN 2021 55
4.3 URINALYSIS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 55
FIGURE 18 DISEASE SCREENING TO HOLD THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 55
4.4 URINALYSIS MARKET, BY REGION, 2021 VS. 2026 56
FIGURE 19 NORTH AMERICA TO DOMINATE THE MARKET IN 2021 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 20 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases 58
5.2.1.2 Rising geriatric population and the subsequent increase in age-associated diseases 58
TABLE 2 ESTIMATED INCREASE IN THE GERIATRIC POPULATION
BY REGION (2019-2050) 59
5.2.1.3 Increasing adoption of POC urine diagnostic tests 59
5.2.2 RESTRAINTS 60
5.2.2.1 Availability of refurbished urine analyzers 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging economies 60
5.2.3.2 Technological advancements in urine analyzers 60
5.2.4 CHALLENGES 61
5.2.4.1 Changing regulatory landscape for the urinalysis market 61
5.3 IMPACT OF COVID-19 ON THE URINALYSIS MARKET 61
5.4 REALISTIC, PESSIMISTIC, AND OPTIMISTIC SCENARIOS 62
5.4.1 URINALYSIS MARKET 62
FIGURE 21 REALISTIC SCENARIO 62
FIGURE 22 PESSIMISTIC SCENARIO 63
FIGURE 23 OPTIMISTIC SCENARIO 63
5.5 PRICING ANALYSIS 64
TABLE 3 PRICE OF URINALYSIS PRODUCTS (2021) 64
5.6 PATENT ANALYSIS 65
5.6.1 PATENT ANALYSIS OF URINALYSIS PRODUCTS 65
5.6.2 PATENT ANALYSIS OF DIPSTICKS 66
5.7 TRADE ANALYSIS 66
5.7.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS 66
5.7.1.1 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (USD Million) 66
5.7.1.2 Import data for diagnostic and laboratory reagents, by country, 2016─2020 (Tons) 67
5.8 VALUE CHAIN ANALYSIS 67
FIGURE 24 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 67
FIGURE 25 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 69
5.9 ECOSYSTEM ANALYSIS OF THE URINALYSIS MARKET 69
FIGURE 26 URINALYSIS MARKET: ECOSYSTEM ANALYSIS 69
5.9.1 ROLE IN ECOSYSTEM 70
5.10 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 4 URINALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.10.1 THREAT OF NEW ENTRANTS 70
5.10.2 THREAT OF SUBSTITUTES 71
5.10.3 BARGAINING POWER OF BUYERS 71
5.10.4 BARGAINING POWER OF SUPPLIERS 71
5.10.5 DEGREE OF COMPETITION 71
5.11 REGULATORY LANDSCAPE 71
5.11.1 NORTH AMERICA 71
5.11.1.1 US 71
5.11.1.2 Canada 72
5.11.2 EUROPE 72
5.11.3 ASIA PACIFIC 72
5.11.3.1 China 72
5.11.3.2 Japan 72
5.11.3.3 India 72
5.11.4 LATIN AMERICA 73
5.11.4.1 Brazil 73
5.11.4.2 MEXICO 73
5.11.5 MIDDLE EAST 73
5.11.6 AFRICA 74
5.12 TECHNOLOGY ANALYSIS 74
5.13 PESTLE ANALYSIS 75
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 76
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR URINALYSIS
PRODUCT MANUFACTURERS 76
5.14.2 REVENUE SHIFT FOR THE URINALYSIS MARKET 76
6 URINALYSIS MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 5 URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 78
TABLE 6 URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 78
6.2 CONSUMABLES 78
6.2.1 PRIMARY NOTES 79
6.2.1.1 Key industry insights 79
TABLE 7 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2016–2019 (USD MILLION) 79
TABLE 8 URINALYSIS CONSUMABLES MARKET, BY TYPE, 2020–2026 (USD MILLION) 79
TABLE 9 URINALYSIS CONSUMABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 80
TABLE 10 URINALYSIS CONSUMABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 80
6.2.2 PREGNANCY & FERTILITY KITS 80
6.2.2.1 Need for rapid pregnancy testing to drive the growth of this market 80
TABLE 11 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION,
2016–2019 (USD MILLION) 81
TABLE 12 URINALYSIS PREGNANCY & FERTILITY KITS MARKET, BY REGION,
2020–2026 (USD MILLION) 81
6.2.3 DIPSTICKS 81
6.2.3.1 Dipsticks are used regularly owing to low costs and standard efficiency 81
TABLE 13 URINALYSIS DIPSTICKS MARKET, BY REGION, 2016–2019 (USD MILLION) 82
TABLE 14 URINALYSIS DIPSTICKS MARKET, BY REGION, 2020–2026 (USD MILLION) 82
6.2.4 DISPOSABLES 82
6.2.4.1 The wide usage of urine collection cups will drive the market demand for disposables 82
TABLE 15 URINALYSIS DISPOSABLES MARKET, BY REGION,
2016–2019 (USD MILLION) 83
TABLE 16 URINALYSIS DISPOSABLES MARKET, BY REGION,
2020–2026 (USD MILLION) 83
6.2.5 REAGENTS 83
6.2.5.1 Increasing use of controls & calibrators to drive the market
growth for reagents 83
TABLE 17 URINALYSIS REAGENTS MARKET, BY REGION, 2016–2019 (USD MILLION) 84
TABLE 18 URINALYSIS REAGENTS MARKET, BY REGION, 2020–2026 (USD MILLION) 84
6.3 INSTRUMENTS 84
TABLE 19 KEY PRODUCTS IN THE INSTRUMENTS MARKET 85
TABLE 20 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 85
TABLE 21 URINALYSIS INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 85
TABLE 22 URINALYSIS INSTRUMENTS MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 23 URINALYSIS INSTRUMENTS MARKET, BY REGION,
2020–2026 (USD MILLION) 86
6.3.1 AUTOMATED URINE ANALYZERS 86
6.3.1.1 Increasing need for automation for shorter turnaround times to drive the market growth for automated urine analyzers 86
TABLE 24 AUTOMATED URINE ANALYZERS MARKET, BY TYPE,
2016–2019 (USD MILLION) 86
TABLE 25 AUTOMATED URINE ANALYZERS MARKET, BY TYPE,
2020–2026 (USD MILLION) 87
TABLE 26 AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 87
TABLE 27 AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 87
6.3.1.2 Integrated urine analyzers 88
6.3.1.2.1 The higher workload in hospitals and laboratories to drive the adoption of integrated urine analyzers 88
TABLE 28 INTEGRATED URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 88
TABLE 29 INTEGRATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 88
6.3.1.3 Sediment urine analyzers 89
6.3.1.3.1 Automated sediment urine analyzers increase the productivity of laboratories and integrate patient data for easy access 89
TABLE 30 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2016–2019 (USD MILLION) 89
TABLE 31 SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2026 (USD MILLION) 89
TABLE 32 SEDIMENT URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 90
TABLE 33 SEDIMENT URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 90
6.3.1.3.2 Microscopy analyzers 90
6.3.1.3.2.1 Increased adoption of automated microscopy analyzers to drive the market growth of this segment 90
TABLE 34 MICROSCOPY ANALYZERS MARKET, BY REGION, 2016–2019 (USD MILLION) 91
TABLE 35 MICROSCOPY ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION) 91
6.3.1.3.3 Flow cytometry analyzers 91
6.3.1.3.3.1 Accuracy and sensitivity of flow cytometry technique to drive the adoption of these analyzers 91
TABLE 36 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 92
TABLE 37 FLOW CYTOMETRY ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 92
6.3.1.4 Biochemical urine analyzers 92
6.3.1.4.1 Increasing incidence of kidney diseases & UTIs to increase the adoption of automated biochemical analyzers 92
TABLE 38 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 93
TABLE 39 AUTOMATED BIOCHEMICAL URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 93
6.3.2 SEMI-AUTOMATED URINE ANALYZERS 93
6.3.2.1 Semi-automated urine analyzers are used extensively in hospitals & clinics due to lower costs and practical efficiency 93
TABLE 40 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 94
TABLE 41 SEMI-AUTOMATED URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 94
6.3.3 POINT-OF-CARE URINE ANALYZERS 94
6.3.3.1 The need for rapid testing to drive the demand for
POC urine analyzers 94
TABLE 42 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION,
2016–2019 (USD MILLION) 95
TABLE 43 POINT-OF-CARE URINE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 95
7 URINALYSIS MARKET, BY TEST TYPE 96
7.1 INTRODUCTION 97
TABLE 44 URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 97
TABLE 45 URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 97
7.2 PREGNANCY & FERTILITY TESTS 97
7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE THE GROWTH OF THIS SEGMENT 97
TABLE 46 PREGNANCY & FERTILITY TESTS MARKET, BY REGION,
2016–2019 (USD MILLION) 98
TABLE 47 PREGNANCY & FERTILITY TESTS MARKET, BY REGION,
2020–2026 (USD MILLION) 98
7.3 BIOCHEMICAL URINALYSIS 98
TABLE 48 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2016–2019 (USD MILLION) 99
TABLE 49 BIOCHEMICAL URINALYSIS MARKET, BY TYPE, 2020–2026 (USD MILLION) 99
TABLE 50 BIOCHEMICAL URINALYSIS MARKET, BY REGION,
2016–2019 (USD MILLION) 99
TABLE 51 BIOCHEMICAL URINALYSIS MARKET, BY REGION,
2020–2026 (USD MILLION) 100
7.3.1 LABORATORY TESTS 100
7.3.1.1 Laboratory tests use automated or semi-automated analyzers 100
TABLE 52 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2016–2019 (USD MILLION) 100
TABLE 53 BIOCHEMICAL URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2026 (USD MILLION) 101
7.3.2 POC TESTS 101
7.3.2.1 The convenience of POC testing drives the growth of this segment 101
TABLE 54 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 55 BIOCHEMICAL URINALYSIS MARKET FOR POC TESTS, BY REGION,
2020–2026 (USD MILLION) 102
7.4 SEDIMENT URINALYSIS 102
7.4.1 THE INCREASING ADOPTION OF AUTOMATED ANALYZERS TO DRIVE THE GROWTH OF THIS SEGMENT 102
TABLE 56 SEDIMENT URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION) 102
TABLE 57 SEDIMENT URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION) 103
8 URINALYSIS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 58 URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 105
TABLE 59 URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 105
8.2 DISEASE SCREENING 105
TABLE 60 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE,
2016–2019 (USD MILLION) 106
TABLE 61 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE,
2020–2026 (USD MILLION) 106
TABLE 62 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION,
2016–2019 (USD MILLION) 106
TABLE 63 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION,
2020–2026 (USD MILLION) 107
8.2.1 URINARY TRACT INFECTIONS 107
8.2.1.1 Increasing prevalence of UTIs to drive the growth of this application segment 107
TABLE 64 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION,
2016–2019 (USD MILLION) 107
TABLE 65 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION,
2020–2026 (USD MILLION) 108
8.2.2 KIDNEY DISEASES 108
8.2.2.1 Rapidly growing geriatric population and the subsequent increase in the prevalence of kidney diseases to drive the market growth 108
TABLE 66 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION,
2016–2019 (USD MILLION) 109
TABLE 67 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION,
2020–2026 (USD MILLION) 109
8.2.3 DIABETES 109
8.2.3.1 Development of advanced analytical tools for diabetes
to drive the market growth 109
TABLE 68 URINALYSIS MARKET FOR DIABETES, BY REGION,
2016–2019 (USD MILLION) 110
TABLE 69 URINALYSIS MARKET FOR DIABETES, BY REGION,
2020–2026 (USD MILLION) 110
8.2.4 LIVER DISEASES 110
8.2.4.1 The high prevalence of liver diseases increases the demand for urinalysis testing 110
TABLE 70 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 71 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION,
2020–2026 (USD MILLION) 111
8.2.5 OTHER DISEASE SCREENING APPLICATIONS 111
TABLE 72 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS,
BY REGION, 2016–2019 (USD MILLION) 112
TABLE 73 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS,
BY REGION, 2020–2026 (USD MILLION) 112
8.3 PREGNANCY AND FERTILITY 112
8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 112
TABLE 74 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION,
2016–2019 (USD MILLION) 113
TABLE 75 URINALYSIS MARKET FOR PREGNANCY AND FERTILITY, BY REGION,
2020–2026 (USD MILLION) 113
9 URINALYSIS MARKET, BY END USER 114
9.1 INTRODUCTION 115
TABLE 76 URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 115
TABLE 77 URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 115
TABLE 78 URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 116
TABLE 79 URINALYSIS END USER MARKET, BY APPLICATION, 2018 (USD MILLION) 116
TABLE 80 URINALYSIS END USER MARKET, BY TEST TYPE, 2018 (USD MILLION) 117
9.2 DIAGNOSTIC LABORATORIES 117
9.2.1 INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO LABORATORIES FOR REDUCED COSTS DRIVES THE MARKET GROWTH 117
TABLE 81 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION,
2016–2019 (USD MILLION) 117
TABLE 82 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION,
2020–2026 (USD MILLION) 118
9.3 HOSPITALS AND CLINICS 118
9.3.1 THE INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE THE MARKET GROWTH FOR THIS END-USER SEGMENT 118
TABLE 83 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION,
2016–2019 (USD MILLION) 119
TABLE 84 URINALYSIS MARKET FOR HOSPITALS AND CLINICS, BY REGION,
2020–2026 (USD MILLION) 119
 
9.4 HOME CARE SETTINGS 119
9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO DRIVE THE GROWTH OF THIS MARKET 119
TABLE 85 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION,
2016–2019 (USD MILLION) 120
TABLE 86 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION,
2020–2026 (USD MILLION) 120
9.5 RESEARCH LABORATORIES & INSTITUTES 120
9.5.1 GROWING FOCUS ON DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO DRIVE THE MARKET GROWTH 120
TABLE 87 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2016–2019 (USD MILLION) 121
TABLE 88 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES,
BY REGION, 2020–2026 (USD MILLION) 121
10 URINALYSIS MARKET, BY REGION 122
10.1 INTRODUCTION 123
TABLE 89 URINALYSIS MARKET, BY REGION, 2016–2019 (USD MILLION) 123
TABLE 90 URINALYSIS MARKET, BY REGION, 2020–2026 (USD MILLION) 123
10.2 NORTH AMERICA 123
FIGURE 27 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT 124
TABLE 91 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 124
TABLE 92 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 125
TABLE 93 NORTH AMERICA: URINALYSIS MARKET, BY END USER,
2016–2019 (USD MILLION) 125
TABLE 94 NORTH AMERICA: URINALYSIS MARKET, BY END USER,
2020–2026 (USD MILLION) 125
TABLE 95 NORTH AMERICA: URINALYSIS END USER MARKET, BY PRODUCT,
2018 (USD MILLION) 126
TABLE 96 NORTH AMERICA: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 126
10.2.1 US 126
10.2.1.1 The US dominated the North American urinalysis market in 2020 126
TABLE 97 US: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 127
TABLE 98 US: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 127
TABLE 99 US: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 128
TABLE 100 US: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 128
TABLE 101 US: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 128
TABLE 102 US: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 128
TABLE 103 US: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 129
TABLE 104 US: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 129
10.2.2 CANADA 129
10.2.2.1 The increasing prevalence of chronic conditions like liver diseases in Canada drives the market growth 129
TABLE 105 CANADA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 130
TABLE 106 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 130
TABLE 107 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 130
TABLE 108 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 131
TABLE 109 CANADA: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 131
TABLE 110 CANADA: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 131
TABLE 111 CANADA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 131
TABLE 112 CANADA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 132
10.3 EUROPE 132
TABLE 113 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 133
TABLE 114 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 133
TABLE 115 EUROPE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 133
TABLE 116 EUROPE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 134
TABLE 117 EUROPE: URINALYSIS END USER MARKET, BY PRODUCT,
2018 (USD MILLION) 134
TABLE 118 EUROPE: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 135
10.3.1 GERMANY 135
10.3.1.1 Increasing healthcare expenditure to drive the market growth in Germany 135
TABLE 119 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 136
TABLE 120 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 136
TABLE 121 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 136
TABLE 122 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 136
TABLE 123 GERMANY: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 137
TABLE 124 GERMANY: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 137
TABLE 125 GERMANY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 137
TABLE 126 GERMANY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 138
10.3.2 UK 138
10.3.2.1 Rising government healthcare expenditure propels market
growth in the UK 138
TABLE 127 UK: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 139
TABLE 128 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 139
TABLE 129 UK: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 139
TABLE 130 UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 139
TABLE 131 UK: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 140
TABLE 132 UK: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 140
TABLE 133 UK: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 140
TABLE 134 UK: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 140
10.3.3 FRANCE 141
10.3.3.1 Rising R&D expenditure in France to drive the market growth 141
TABLE 135 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 141
TABLE 136 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 141
TABLE 137 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 142
TABLE 138 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 142
TABLE 139 FRANCE: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 142
TABLE 140 FRANCE: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 142
TABLE 141 FRANCE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 143
TABLE 142 FRANCE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 143
10.3.4 ITALY 143
10.3.4.1 Age-related chronic kidney disease owing to a large senior population in Italy to drive the market growth for urinalysis 143
TABLE 143 ITALY: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 144
TABLE 144 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 144
TABLE 145 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 144
TABLE 146 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 144
TABLE 147 ITALY: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 145
TABLE 148 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 145
TABLE 149 ITALY: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 145
TABLE 150 ITALY: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 145
10.3.5 SPAIN 146
10.3.5.1 The rising geriatric population in Spain is expected to drive the market growth 146
TABLE 151 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 146
TABLE 152 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 146
TABLE 153 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 146
TABLE 154 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 147
TABLE 155 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 147
TABLE 156 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 147
TABLE 157 SPAIN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 147
TABLE 158 SPAIN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 148
10.3.6 REST OF EUROPE 148
TABLE 159 ROE: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 148
TABLE 160 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 149
TABLE 161 ROE: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 149
TABLE 162 ROE: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 149
TABLE 163 ROE: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 149
TABLE 164 ROE: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 150
TABLE 165 ROE: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 150
TABLE 166 ROE: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 150
 
10.4 ASIA PACIFIC 151
FIGURE 28 APAC: URINALYSIS MARKET SNAPSHOT 152
TABLE 167 APAC: URINALYSIS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 153
TABLE 168 APAC: URINALYSIS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 153
TABLE 169 APAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 153
TABLE 170 APAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 154
TABLE 171 APAC: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 154
TABLE 172 APAC: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 155
10.4.1 CHINA 155
10.4.1.1 Improving healthcare infrastructure in China supports the growth of the urinalysis market 155
TABLE 173 CHINA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 156
TABLE 174 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 156
TABLE 175 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 157
TABLE 176 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 157
TABLE 177 CHINA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 157
TABLE 178 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 157
TABLE 179 CHINA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 158
TABLE 180 CHINA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 158
10.4.2 INDIA 158
10.4.2.1 Increasing private & public investments in India’s healthcare system to drive the market growth for urinalysis testing 158
TABLE 181 INDIA: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 159
TABLE 182 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 159
TABLE 183 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 159
TABLE 184 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 159
TABLE 185 INDIA: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 160
TABLE 186 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 160
TABLE 187 INDIA: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 160
TABLE 188 INDIA: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 160
10.4.3 JAPAN 161
10.4.3.1 Favorable regulatory framework to drive the market growth in Japan 161
TABLE 189 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 161
TABLE 190 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 161
TABLE 191 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 162
TABLE 192 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 162
TABLE 193 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 162
TABLE 194 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 162
TABLE 195 JAPAN: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 163
TABLE 196 JAPAN: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 163
10.4.4 REST OF ASIA PACIFIC 163
TABLE 197 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 164
TABLE 198 ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 164
TABLE 199 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2016–2019 (USD MILLION) 164
TABLE 200 ROAPAC: URINALYSIS MARKET, BY TEST TYPE, 2020–2026 (USD MILLION) 164
TABLE 201 ROAPAC: URINALYSIS MARKET, BY APPLICATION,
2016–2019 (USD MILLION) 165
TABLE 202 ROAPAC: URINALYSIS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 165
TABLE 203 ROAPAC: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 165
TABLE 204 ROAPAC: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 165
10.5 REST OF THE WORLD 166
10.5.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE THE HEALTHCARE INFRASTRUCTURE IN THE REGION TO DRIVE THE MARKET GROWTH FOR URINALYSIS PRODUCTS 166
TABLE 205 ROW: URINALYSIS MARKET, BY END USER, 2016–2019 (USD MILLION) 167
TABLE 206 ROW: URINALYSIS MARKET, BY END USER, 2020–2026 (USD MILLION) 167
TABLE 207 ROW: URINALYSIS END USER MARKET, BY PRODUCT, 2018 (USD MILLION) 167
TABLE 208 ROW: URINALYSIS END USER MARKET, BY APPLICATION,
2018 (USD MILLION) 168
11 COMPETITIVE LANDSCAPE 169
11.1 OVERVIEW 169
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 169
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE URINALYSIS MARKET 169
TABLE 209 OVERVIEW OF STRATEGIES DEPLOYED BY KEY URINALYSIS PRODUCT MANUFACTURING COMPANIES 169
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 170
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN
THE URINALYSIS MARKET 171
11.4 MARKET SHARE ANALYSIS 171
FIGURE 30 URINALYSIS MARKET SHARE, BY KEY PLAYER (2020) 172
TABLE 210 URINALYSIS MARKET: DEGREE OF COMPETITION 172
11.4.1 URINALYSIS MARKET RANKING, BY TEST TYPE 173
11.4.1.1 Biochemical urinalysis 173
TABLE 211 GLOBAL BIOCHEMICAL URINALYSIS MARKET, BY KEY PLAYERS, 2020 173
11.4.1.2 Sediment urinalysis 174
TABLE 212 GLOBAL SEDIMENT URINALYSIS MARKET, BY KEY PLAYERS, 2020 174
11.4.1.3 Pregnancy & fertility tests 174
TABLE 213 GLOBAL PREGNANCY & FERTILITY TESTS MARKET, BY KEY PLAYERS, 2020 174
11.5 COMPANY EVALUATION QUADRANT 174
11.5.1 LIST OF EVALUATED VENDORS 174
11.5.2 STARS 174
11.5.3 EMERGING LEADERS 174
11.5.4 PERVASIVE PLAYERS 175
11.5.5 PARTICIPANTS 175
FIGURE 31 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 175
11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020) 176
11.6.1 PROGRESSIVE COMPANIES 176
11.6.2 STARTING BLOCKS 176
11.6.3 RESPONSIVE COMPANIES 176
11.6.4 DYNAMIC COMPANIES 176
FIGURE 32 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020 177
11.7 COMPETITIVE BENCHMARKING 177
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE URINALYSIS MARKET 177
TABLE 214 COMPANY PRODUCT TYPE FOOTPRINT 178
TABLE 215 COMPANY GEOGRAPHICAL FOOTPRINT 178
11.8 COMPETITIVE SCENARIO 178
11.8.1 PRODUCT LAUNCHES AND REGULATORY APPROVALS 178
TABLE 216 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS 178
11.8.2 DEALS 179
TABLE 217 KEY DEALS 179
11.8.3 URINALYSIS: OTHER DEVELOPMENTS 179
TABLE 218 OTHER KEY DEVELOPMENTS 179
12 COMPANY PROFILES 180
12.1 KEY PLAYERS 180
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win,
Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 SIEMENS HEALTHINEERS AG 180
TABLE 219 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 180
FIGURE 34 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020) 181
12.1.2 F. HOFFMANN-LA ROCHE 184
TABLE 220 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 184
FIGURE 35 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 185
12.1.3 CARDINAL HEALTH, INC. 187
TABLE 221 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 187
FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2020) 188
12.1.4 ABBOTT LABORATORIES 191
TABLE 222 ABBOTT LABORATORIES: BUSINESS OVERVIEW 191
FIGURE 37 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 192
12.1.5 DANAHER CORPORATION 195
TABLE 223 DANAHER CORPORATION: BUSINESS OVERVIEW 195
FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 196
12.1.6 SYSMEX CORPORATION 198
TABLE 224 SYSMEX CORPORATION: BUSINESS OVERVIEW 198
FIGURE 39 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020) 199
12.1.7 THERMO FISHER SCIENTIFIC INC. 201
TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 201
FIGURE 40 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 202
12.1.8 QUIDEL CORPORATION 204
TABLE 226 QUIDEL CORPORATION: BUSINESS OVERVIEW 204
FIGURE 41 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020) 205
12.1.9 BECTON, DICKINSON AND COMPANY 207
TABLE 227 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 207
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 208
12.1.10 BIO-RAD LABORATORIES 210
TABLE 228 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 210
FIGURE 43 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020) 211
12.1.11 EKF DIAGNOSTICS 213
TABLE 229 EKF DIAGNOSTICS: BUSINESS OVERVIEW 213
FIGURE 44 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2020) 214
12.2 OTHER PLAYERS 215
12.2.1 ARKRAY, INC. 215
12.2.2 ACON LABORATORIES, INC. 217
12.2.3 77 ELEKTRONIKA KFT. 219
12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD. 221
12.2.5 DIRUI INDUSTRIAL CO., LTD. 222
12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 224
12.2.7 BIOBASE GROUP 225
12.2.8 ERBA MANNHEIM 226
12.2.9 ALPHATECH SCIENTIFIC 227
12.2.10 TECO DIAGNOSTICS 228
12.2.11 ANALYTICON BIOTECHNOLOGIES AG 229
12.2.12 BIOWAY BIOTECHNOLOGY 230
12.2.13 HIGH TECHNOLOGY INC. 231
12.2.14 AGAPPE DIAGNOSTICS LTD. 232
12.2.15 GENRUI BIOTECH INC. 233
12.2.16 SPINREACT S.A. 233
12.2.17 DIALAB GMBH 233
12.2.18 QUANTIMETRIX CORPORATION 234
12.2.19 BIOCARE CORPORATION 234
12.2.20 RANDOX LABORATORIES LTD. 234
12.2.21 PZ CORMAY SA 235
12.2.22 YD DIAGNOSTICS 235
12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD. 235
12.2.24 RAYTO LIFE AND ANALYTICAL SCIENCES CO., LTD. 236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 237
13.1 INSIGHTS FROM INDUSTRY EXPERTS 237
13.2 DISCUSSION GUIDE 238
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 240
13.4 AVAILABLE CUSTOMIZATIONS 242
13.5 RELATED REPORTS 242
13.6 AUTHOR DETAILS 243

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127